Johnson & Johnson Innovation - JJDC, Inc. PTGX Holdings History
Number of Shares
2.45 Mil
Current Holdings Value*
$109.92 Mil
% of Portfolio
11.24%
Total Estimate Gain
$108.62 Mil
% of Total Estimate Gain
450.71%
Johnson & Johnson Innovation - JJDC, Inc.'s Protagonist Therapeutics Inc Holding Summary
As of 2021-06-30, Johnson & Johnson Innovation - JJDC, Inc. held 2.45 Mil shares of Protagonist Therapeutics Inc(PTGX), totaling $109.92 Mil. This investment constitutes 11.24% of their stock portfolio, and Johnson & Johnson Innovation - JJDC, Inc. now holds 5.04% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.
The initial trade took place in 2019Q4. Based on historical transaction data and PTGX's current price of $54.19, Johnson & Johnson Innovation - JJDC, Inc.'s estimated gain on his PTGX holdings is $108.62 Mil, reflecting a 450.71% gain to date.
Johnson & Johnson Innovation - JJDC, Inc. PTGX ($54.19) Holding Chart
Johnson & Johnson Innovation - JJDC, Inc. PTGX ($54.19) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers